LifeLabs Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:LifeLabs Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010877
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LifeLabs Inc (LifeLabs) is a laboratory testing service provider that monitors heart disease and identifies neurological disorders and pinpoint allergies. The laboratory’s services include clinical studies and services, drug and alcohol screening, employee wellness, hospital lab services, medical surveillance, occupational health services, specialized clinical lab testing, cardiac monitoring and mobile lab services, among others. It provides broad range of community laboratory tests, national access to highly specialized clinical tests, laboratory testing and management for hospitals, professional health services for employers, professional health services for insurers and government agencies. LifeLabs works in partnership with charitable organizations for health research, education and technology and improvements to treat and manage diseases. The laboratory offers diagnostic imaging services. LifeLabs is headquartered in Toronto, Ontario, Canada.

LifeLabs Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LifeLabs Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
LifeLabs Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
LifeLabs Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
LifeLabs Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
LifeLabs Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
LifeLabs Inc, Medical Equipment, Deal Details 10
Partnerships 10
LifeLabs Enters into Licensing Agreement with Transgenomic 10
Natera Enters into Agreement with LifeLabs for Non-Invasive Prenatal Test 11
LifeLabs Enters Co Marketing Agreement With Contextual Genomics 12
Asset Transactions 13
Universal Biosensors to Acquire Hemostasis Reference Lab Business from LifeLabs 13
Acquisition 14
LifeLabs Medical Completes Acquisition Of CML HealthCare For US$1.16 Billion 14
LifeLabs Completes Acquisition Of BC Biomedical, Lab Services Provider 16
LifeLabs Inc – Key Competitors 17
LifeLabs Inc – Key Employees 18
LifeLabs Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Jan 07, 2016: Chris Carson to Join LifeLabs as Vice-President, Partner Relations and Transformation 20
Legal and Regulatory 21
Mar 07, 2016: Institute for Quality Management in Healthcare Assessment and Accreditation 21
Other Significant Developments 22
Apr 18, 2016: LifeLabs Announces Extended Hours of Service in St. Thomas 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
LifeLabs Inc, Medical Equipment, Key Facts 2
LifeLabs Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
LifeLabs Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
LifeLabs Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
LifeLabs Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
LifeLabs Inc, Deals By Market, 2011 to YTD 2017 8
LifeLabs Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
LifeLabs Enters into Licensing Agreement with Transgenomic 10
Natera Enters into Agreement with LifeLabs for Non-Invasive Prenatal Test 11
LifeLabs Enters Co Marketing Agreement With Contextual Genomics 12
Universal Biosensors to Acquire Hemostasis Reference Lab Business from LifeLabs 13
LifeLabs Medical Completes Acquisition Of CML HealthCare For US$1.16 Billion 14
LifeLabs Completes Acquisition Of BC Biomedical, Lab Services Provider 16
LifeLabs Inc, Key Competitors 17
LifeLabs Inc, Key Employees 18
LifeLabs Inc, Other Locations 19
LifeLabs Inc, Subsidiaries 19

★海外企業調査レポート[LifeLabs Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cadila Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Cadila Pharmaceuticals Ltd (Cadila Pharmaceuticals) is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. The company's products include active pharmaceutical ingredients (API) and pharmaceutical formulations. Its business includes contract research …
  • TIM SpA (TIT):企業の財務・戦略的SWOT分析
    TIM SpA (TIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Prexton Therapeutics SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Prexton Therapeutics SA (Prexton) is a developer of drugs for Parkinson’s disease and other brain disorders. The company designs and develops mGluR4 positive allosteric modulator compounds for the treatment for Parkinson’s disease. It also develops positive allosteric modulators, or PAMs to …
  • Vygon SA-医療機器分野:企業M&A・提携分析
    Summary Vygon SA (Vygon) is a medical specialty company that designs, manufactures and markets single use medical and surgical products. It offers products in the areas of paediatrics and neonatology, emergency and intensive care units, anaesthesia, support for post-operative pain relief, vascular a …
  • GoPro, Inc.:戦略・SWOT・企業財務分析
    GoPro, Inc. - Strategy, SWOT and Corporate Finance Report Summary GoPro, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Iconic Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Iconic Therapeutics Inc (Iconic Therapeutics) is a biopharmaceutical company that provides translation of scientific insight into breakthrough medicines. The company offers development of tissue factor in angiogenesis, inflammation, and metastasis that led to develop new approach to retinal …
  • Innovative Solutions and Support, Inc.:企業の戦略・SWOT・財務情報
    Innovative Solutions and Support, Inc. - Strategy, SWOT and Corporate Finance Report Summary Innovative Solutions and Support, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Assore Limited:企業の戦略・SWOT・財務情報
    Assore Limited - Strategy, SWOT and Corporate Finance Report Summary Assore Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Schiller AG:企業の戦略的SWOT分析
    Schiller AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Premier Oil Plc (PMO):石油・ガス:M&Aディール及び事業提携情報
    Summary Premier Oil Plc (Premier Oil) is an independent upstream oil and gas company. It explores for, develops and produces crude oil and natural gas. The company has interests in the North Sea, South East Asia, Pakistan, the Falkland Islands and Latin America. It explores under-explored proven hyd …
  • Slovnaft AS (1SLN01AE):企業の財務・戦略的SWOT分析
    Slovnaft AS (1SLN01AE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Arqvia Group Ltd:企業の戦略・SWOT・財務分析
    Arqvia Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Arqvia Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • GNC Holdings, Inc.:企業の戦略・SWOT・財務情報
    GNC Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary GNC Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Petoro AS-石油・ガス分野:企業M&A・提携分析
    Summary Petoro AS (Petoro) is an oil and gas asset management company. The company manages Norwegian state’s direct financial interests (SDFI) in Norwegian Continental Shelf (NCS) oil and gas assets. It has the responsibility for and to attend to the commercial aspects related to the state's direct …
  • Interface Biologics Inc:製品パイプライン分析
    Summary Interface Biologics Inc (IBI) is a developer transformative biomedical polymer technology. The company offers anti-thrombogenic and combination drug delivery devices. Its blood contacting medical devices uses Endexo technology address problems related to thrombosis. IBI’s technologies includ …
  • Lumos Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lumos Pharma Inc (Lumos Pharma) is a developer of novel therapies for the treatment of rare and neglected diseases. The company’s pipeline product includes LUM-001, LUM-201 and LUM-301. Its lead compound LUM001, is a small and planar molecule used for the treatment of rare disease, creatine …
  • L’Oreal USA Inc:企業の戦略的SWOT分析
    L'Oreal USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • CS Energy Ltd:企業の戦略的SWOT分析
    CS Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Alexza Pharmaceuticals Inc:企業の戦略的SWOT分析
    Alexza Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Credit Agricole CIB S.A.:企業の戦略的SWOT分析
    Credit Agricole CIB S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆